No Matches Found
No Matches Found
No Matches Found
Caprolactam Chemicals Ltd
Caprolactam Chemicals Faces Intense Selling Pressure Amid Consecutive Gains
Caprolactam Chemicals Ltd has encountered a rare market phenomenon today, with the stock registering a lower circuit and an exclusive queue of sell orders, signalling extreme selling pressure and distress selling. Despite a strong run of consecutive gains over the past eight days, the stock’s current trading session reveals a stark absence of buyers, raising concerns about market sentiment and potential volatility ahead.
Caprolactam Chemicals Faces Intense Selling Pressure Amid Lower Circuit Lock
Caprolactam Chemicals Ltd witnessed a sharp decline today as the stock hit its lower circuit, marked by an overwhelming presence of sell orders and an absence of buyers. This extreme selling pressure signals distress among investors, with the stock closing down 5.00% against a marginal 0.30% fall in the Sensex, underscoring the severity of the sell-off in the commodity chemicals sector.
Caprolactam Chemicals Hits New 52-Week High at Rs.69
Caprolactam Chemicals has reached a significant milestone by touching a new 52-week high of Rs.69, marking a notable phase of momentum for the commodity chemicals company. This achievement reflects a sustained upward trend over the past week, underscoring the stock’s strong performance relative to its sector and broader market indices.
Caprolactam Chemicals Hits New 52-Week High at Rs.66.42
Caprolactam Chemicals has reached a significant milestone by touching a new 52-week high of Rs.66.42, marking a notable phase of momentum in the commodity chemicals sector. This achievement reflects a sustained upward trend over recent sessions, underscoring the stock’s robust performance amid a mixed market backdrop.
Caprolactam Chemicals Surges with Unprecedented Buying Interest, Hits New 52-Week High
Caprolactam Chemicals has witnessed extraordinary buying momentum, registering a 4.96% gain today and touching a new 52-week high of Rs. 66.42. The stock’s performance starkly contrasts with the broader market, as the Sensex declined by 0.25%, underscoring the robust demand and absence of sellers in the queue.
Caprolactam Chemicals Surges with Unprecedented Buying Interest, Edging Near 52-Week High
Caprolactam Chemicals Ltd witnessed extraordinary buying momentum today, registering a 5.0% gain and trading exclusively at its intraday high with no sellers in the queue. This remarkable demand has propelled the stock to within 2.67% of its 52-week high, signalling a potential multi-day upper circuit scenario amid sustained investor enthusiasm.
Is Caprolactam Chem overvalued or undervalued?
As of November 28, 2025, Caprolactam Chem is considered overvalued with a high PE ratio of 2771.50 and other metrics significantly above industry norms, making it a less prudent investment despite a recent 20.14% stock return.
Caprolactam Chemicals Surges with Unprecedented Buying Interest and Upper Circuit Lock
Caprolactam Chemicals has witnessed extraordinary buying momentum, locking in an upper circuit with no sellers in the queue. The stock’s performance today highlights a rare market phenomenon where demand overwhelms supply, signalling potential for a sustained multi-day rally.
Caprolactam Chemicals Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit
Caprolactam Chemicals has witnessed extraordinary buying momentum, registering a sharp 4.99% gain today with only buy orders in the queue. This rare market phenomenon signals a potential multi-day upper circuit scenario, reflecting robust investor enthusiasm amid a subdued broader market.
Caprolactam Chemicals Surges with Unprecedented Buying Interest and Upper Circuit Lock
Caprolactam Chemicals Ltd has witnessed extraordinary buying momentum, locking in an upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and a potential multi-day circuit scenario, signalling robust investor interest in the commodity chemicals sector.
Caprolactam Chemicals Surges with Unprecedented Buying Interest and Upper Circuit Lock
Caprolactam Chemicals has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a potential multi-day circuit scenario, signalling robust investor interest in the commodity chemicals sector.
Caprolactam Chemicals Sees Unprecedented Buying Interest, Edges Towards Multi-Day Upper Circuit
Caprolactam Chemicals has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and the potential for a sustained multi-day circuit scenario, signalling strong investor interest in the commodity chemicals sector.
Is Caprolactam Chem overvalued or undervalued?
As of November 18, 2025, Caprolactam Chem is considered undervalued with an attractive rating despite a high PE ratio of 2126.12, lagging behind peers like Cipla and Dr. Reddy's Labs, and has a year-to-date return of -16.12% compared to the Sensex's 8.36%.
Is Caprolactam Chem overvalued or undervalued?
As of November 17, 2025, Caprolactam Chem is fairly valued with a PE ratio of 2297.24 and an EV to EBITDA of 13.31, despite a year-to-date return of -9.36%, while comparing favorably to peers like Sun Pharma and Cipla.
Caprolactam Chemicals Q2 FY26: Profit Surge Masks Persistent Margin Volatility
Caprolactam Chemicals Ltd., a micro-cap player in the commodity chemicals sector with a market capitalisation of ₹21.00 crores, posted a net profit of ₹0.13 crores in Q2 FY26, marking a dramatic recovery from the previous quarter's ₹0.36 crores profit. However, the company's stock has struggled over the past year, declining 3.96% even as the broader market gained 9.50%, raising questions about the sustainability of this operational turnaround amidst persistent margin volatility and weak institutional confidence.
Caprolactam Chemicals Ltd Faces Selling Pressure with 2.50% Decline Amid Ongoing Losses
Caprolactam Chemicals Ltd is experiencing notable selling pressure, with the stock declining for consecutive days. Despite a slight weekly gain, its year-to-date performance shows a significant decline compared to the Sensex. Factors such as erratic trading patterns and lack of buying interest contribute to the bearish sentiment surrounding the stock.
How has been the historical performance of Caprolactam Chem?
Caprolactam Chem has experienced significant declines in net sales and profitability, with net sales dropping from 9.84 Cr in March 2023 to 6.74 Cr in March 2025, and profit after tax turning negative at -0.71 Cr. The company faces ongoing financial difficulties, reflected in increased liabilities and stagnant cash flow.
Caprolactam Chemicals Ltd Faces Selling Pressure with 2.44% Decline Amid Yearly Losses
Caprolactam Chemicals Ltd is experiencing significant selling pressure, continuing a trend of losses despite recent short-term outperformance against the Sensex. The stock has shown a year-to-date decline, contrasting with the Sensex's positive return, amid market volatility and sector challenges in the commodity chemicals industry.
Caprolactam Chemicals Ltd Surges 168.34% Over Five Years Despite Recent 0.49% Decline Today
Caprolactam Chemicals Ltd is experiencing notable buying interest despite recent losses, including a 6.84% decline over three days. The stock has struggled year-to-date but has shown significant growth over five years. Its trading activity remains erratic, and it is currently below key moving averages, indicating a bearish trend.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
